跳至主要内容
临床试验/NL-OMON44619
NL-OMON44619已完成不适用

An observational study to determine the pharmacokinetics of pemetrexed with and without hyperhydration during cisplatin administration (HYDRA). - Influence of hyperhydration on pemetrexed pharmacokinetics (HYDRA)

Jeroen Bosch Ziekenhuis0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. *18 years old
  • 2. Planned for treatment with cisplatin/pemetrexed combination therapy followed by pemetrexed maintenance therapy as a part of routine care.
  • 3. Creatinine clearance * 45ml/min
  • 4. Subject is able and willing to sign the Informed Consent Form.

排除标准

  • 1. Patients that suffer from conditions that affect hemostasis in a way that blood drawing is complicated (to be assessed by physician) are excluded.

研究者

发起方
Jeroen Bosch Ziekenhuis

相似试验